| Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab U De Giorgi, G Procopio, D Giannarelli, R Sabbatini, A Bearz, S Buti, ... Clinical Cancer Research 25 (13), 3839-3846, 2019 | 183 | 2019 |
| Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases P Queirolo, F Spagnolo, PA Ascierto, E Simeone, P Marchetti, A Scoppola, ... Journal of neuro-oncology 118, 109-116, 2014 | 129 | 2014 |
| Urinary mevalonate excretion rate in type 2 diabetes: role of metabolic control A Scoppola, FR Montecchi, G Menzinger, A Lala Atherosclerosis 156 (2), 357-361, 2001 | 101 | 2001 |
| Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme U De Giorgi, G Cartenì, D Giannarelli, U Basso, L Galli, E Cortesi, ... BJU international 123 (1), 98-105, 2019 | 78 | 2019 |
| Treatment-related side effects and quality of life in cancer patients E Mazzotti, GC Antonini Cappellini, S Buconovo, R Morese, A Scoppola, ... Supportive Care in Cancer 20, 2553-2557, 2012 | 76 | 2012 |
| Dermoscopic patterns of cutaneous melanoma metastases R Bono, AR Giampetruzzi, F Concolino, P Puddu, A Scoppola, F Sera, ... Melanoma research 14 (5), 367-373, 2004 | 66 | 2004 |
| Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer F Grossi, C Genova, L Crinò, A Delmonte, D Turci, D Signorelli, A Passaro, ... European Journal of Cancer 123, 72-80, 2019 | 65 | 2019 |
| Possible Mechanism and Treatment of o,p'DDD-induced Hypercholesterolaemia VMG Maher, PJ Trainer, A Scoppola, JV Anderson, GR Thompson, ... QJM: An International Journal of Medicine 84 (2), 671-679, 1992 | 63 | 1992 |
| Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. A Scoppola, VM Maher, GR Thompson, NB Rendell, GW Taylor Journal of lipid research 32 (6), 1057-1060, 1991 | 56 | 1991 |
| Predictors of existential and religious well-being among cancer patients E Mazzotti, F Mazzuca, C Sebastiani, A Scoppola, P Marchetti Supportive Care in Cancer 19, 1931-1937, 2011 | 50 | 2011 |
| Effects of insulin on cholesterol synthesis in type II diabetes patients A Scoppola, G Testa, S Frontoni, E Maddaloni, S Gambardella, ... Diabetes Care 18 (10), 1362-1369, 1995 | 47 | 1995 |
| Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatment S Gambardella, S Frontoni, A Lala, MG Felici, V Spallone, A Scoppola, ... American Heart Journal 122 (4), 1232-1238, 1991 | 47 | 1991 |
| Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness E Pagani, F Ruffini, GC Antonini Cappellini, A Scoppola, C Fortes, ... International Journal of Oncology 48 (4), 1581-1589, 2016 | 44 | 2016 |
| High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanoma E Alvino, F Passarelli, E Cannavò, C Fortes, S Mastroeni, S Caporali, ... American journal of clinical pathology 142 (1), 121-132, 2014 | 29 | 2014 |
| Information Needs of Patients With Melanoma. S Passalacqua, ZC Di Rocco, C Di Pietro, A Mozzetta, S Tabolli, ... Clinical Journal of Oncology Nursing 16 (6), 2012 | 27 | 2012 |
| Plasma mevalonate concentrations in uremic patients A Scoppola, P De Paolis, G Menzinger, A Lala, S Di Giulio Kidney international 51 (3), 908-912, 1997 | 21 | 1997 |
| Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib S Caporali, E Alvino, PM Lacal, F Ruffini, L Levati, L Bonmassar, ... Oncotarget 8 (69), 113472, 2017 | 17 | 2017 |
| Italian cohort of ipilimumab expanded access programme (EAP): Efficacy, safety, and correlation with mutation status in metastatic melanoma patients. P Queirolo, F Spagnolo, M Altomonte, V Chiarion-Sileni, J Pigozzo, ... Journal of Clinical Oncology 31 (15_suppl), 9070-9070, 2013 | 16 | 2013 |
| Italian guidelines for the management of non-functioning benign and locally symptomatic thyroid nodules E Papini, A Crescenzi, A D’Amore, M Deandrea, A De Benedictis, ... Endocrine, Metabolic & Immune Disorders Drug Targets 23 (6), 876, 2023 | 10 | 2023 |
| IgE, IgG4 and IgG response to tissue-specific and environmental antigens in patients affected by cancer D Zennaro, C Capalbo, E Scala, M Liso, E Spillner, M Penichet, J Singer, ... Allergy 66, 100-101, 2011 | 8 | 2011 |
